These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 2438334)

  • 21. Subsets of Lyt-2+ cells defined by differential expression of the 9F3 antigen: alterations in mice of the lpr/lpr genotype.
    Dumont FJ; Habbersett RC; Coker LZ
    J Immunol; 1985 Jan; 134(1):196-203. PubMed ID: 3880569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of T lymphocytes through the Ly-6 pathway is defective in A strain mice.
    Malek TR; Shevach EM; Danis KM
    J Immunol; 1989 Jul; 143(2):439-45. PubMed ID: 2525586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsets.
    Flood PM; Murphy DB; Horowitz M; LeClair KP; Smith FR; Stockert E; Palladino MA; DeLeo AB
    J Immunol; 1985 Jul; 135(1):63-72. PubMed ID: 2987354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thy-1-negative and Ly-1-negative variants of T cells produce interleukin 2 in response to mitogens.
    Hollander N
    J Immunol; 1987 Jul; 139(2):437-42. PubMed ID: 2885371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes.
    Sobel ES; Yokoyama WM; Shevach EM; Eisenberg RA; Cohen PL
    J Immunol; 1993 Jan; 150(2):673-82. PubMed ID: 8380429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM; Szewczuk MR
    Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
    Bamezai A; Goldmacher V; Reiser H; Rock KL
    J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a bone marrow-associated Ly-6 determinant on the T cell population expanding in the lymph nodes of the autoimmune mouse strain MRL/Mp-lpr/lpr.
    Melino MR; Dumont FJ; Habbersett RC; Hansen TH
    J Immunol; 1983 Apr; 130(4):1843-7. PubMed ID: 6601141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 2 responses of lpr and normal L3T4-/Lyt-2- T cells induced by TPA plus A23187.
    Katagiri K; Katagiri T; Eisenberg RA; Ting J; Cohen PL
    J Immunol; 1987 Jan; 138(1):149-56. PubMed ID: 3097142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus.
    Yeh ET; Reiser H; Daley J; Rock KL
    J Immunol; 1987 Jan; 138(1):91-7. PubMed ID: 3023490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subpopulations of CD4- CD8- murine thymocytes: differences in proliferation rate in vivo and proliferative responses in vitro.
    Ewing T; Egerton M; Wilson A; Scollay R; Shortman K
    Eur J Immunol; 1988 Feb; 18(2):261-8. PubMed ID: 2894996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A monoclonal antibody (100C5) to the Lyt-2-T cell population expanding in MRL/Mp-lpr/lpr mice detects a surface antigen normally expressed on Lyt-2+ cells and B cells.
    Dumont FJ; Habbersett RC; Nichols EA; Treffinger JA; Tung AS
    Eur J Immunol; 1983 Jun; 13(6):455-9. PubMed ID: 6602708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
    Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective expression of the Ly-6C.2 epitope on Lyt-2+ T cells that can develop in the absence of thymic influence.
    Leo O; Foo M; Forman J; Shivakumar S; Rabinowitz R; Bluestone JA
    J Immunol; 1988 Jul; 141(1):37-44. PubMed ID: 2454263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha/beta enhances the expression of Ly-6 antigens on T cells in vivo and in vitro.
    Dumont FJ; Coker LZ
    Eur J Immunol; 1986 Jul; 16(7):735-40. PubMed ID: 3487457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Lyt-2+ (CD8+) and L3T4+ (CD4+) T cell subsets by anti-receptor antibody.
    Hathcock KS; Segal DM; Hodes RJ
    J Immunol; 1989 Apr; 142(7):2181-6. PubMed ID: 2784455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated peripheral T cells from GvHR recipients exhibit defective IL-2R expression, IL-2 production, and proliferation in response to activation stimuli.
    Levy RB; Jones M; Cray C
    J Immunol; 1990 Dec; 145(12):3998-4005. PubMed ID: 1979582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.